Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study.

Eun-Jeong Joo Jae-Hoon Ko Seong Eun Kim Seung Ji Kang Ji Hyeon Baek Eun-Young Heo Hye Jin Shi Joong Sik Eom Pyeong Gyun Choe Seongman Bae Sang Hyun Ra Da-Young Kim Baek-Nam Kim Yu-Min Kang Ji Yeon Kim Jin Won Chung Hyun Ha Chang Shin-Woo Kim Shinhyea Cheon Yoonseon Park Heun Choi Eun Jung Lee Bo Young Lee Jung Wan Park Yu Jin Sohn Jung Yeon Heo Sung Han Kim Kyong-Ran Peck

Published in: Journal of Korean medical science (2021)

The remdesivir group showed clinical and virologic benefit in terms of MV requirement and viral load reduction, supporting remdesivir treatment for severe COVID-19.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
systematic review
hiv infected
respiratory syndrome coronavirus
early onset
cross sectional
replacement therapy
smoking cessation